1.黑龙江中医药大学(黑龙江 哈尔滨 150040)
王培基,男,硕士研究生,主要从事中医脏腑证候及疾病防治机理的研究工作
桑希生,教授,硕士研究生导师; E-mail: sangxisheng@126.com
扫 描 看 全 文
王培基,周晓洁,桑希生.牡蛎肝脏保护作用的有效成分及机制研究进展[J].上海中医药杂志,2023,57(8):33-37.
WANG Peiji,ZHOU Xiaojie,SANG Xisheng.Research progress on active ingredients and mechanisms of hepatoprotective effect of oysters[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(8):33-37.
王培基,周晓洁,桑希生.牡蛎肝脏保护作用的有效成分及机制研究进展[J].上海中医药杂志,2023,57(8):33-37. DOI: 10.16305/j.1007-1334.2023.2304001.
WANG Peiji,ZHOU Xiaojie,SANG Xisheng.Research progress on active ingredients and mechanisms of hepatoprotective effect of oysters[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(8):33-37. DOI: 10.16305/j.1007-1334.2023.2304001.
综述牡蛎肝脏保护作用的有效成分及机制研究进展。牡蛎肝脏保护作用的有效成分主要包括多糖、牛磺酸、蛋白质(活性肽)以及微量元素等,其作用机制包括抗炎、抗氧化、改善脂质代谢、调控肠道菌群等。
This article reviews the research progress on the active ingredients and mechanisms of hepatoprotective effects of oysters. The active ingredients of hepatoprotective effect of oyster soft tissue mainly include polysaccharide, taurine, protein (active peptide) and microelement, etc. The mechanisms of action are related to anti-inflammation, antioxidation, improvement of lipid metabolism, and regulation of gut microbiota, etc.
牡蛎肝脏疾病酒精性肝病自身免疫性肝病有效成分作用机制研究进展
oysterliver diseasesalcoholic liver diseaseautoimmune liver diseaseactive ingredientmechanism of actionresearch progress
国家药典委员会. 中华人民共和国药典(2020年版):一部[M]. 北京:中国医药科技出版社,2020: 1902.
曾利荣,张尔贤. 牡蛎的食用与药用价值及其开发利用[J]. 自然杂志,1998, 20(6): 322-325.
桑希生,李庆云,徐强,等. 牡蛎汤对免疫性肝损伤小鼠肝组织NO、IL-2和TNF-α的影响[J]. 中医药信息,2007, 137(5): 68-69.
WANG F S, FAN J G, ZHANG Z, et al. The global burden of liver disease: the major impact of China[J]. Hepatology, 2014, 60(6): 2099-2108.
中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 中华肝脏病杂志,2015, 23(11): 810-820.
刘志芳,赵前程,刘志东,等. 贝类多糖研究进展[J]. 食品与发酵工业,2021, 47(9): 299-306.
SHI X, MA H, TONG C, et al. Hepatoprotective effect of a polysaccharide from Crassostrea gigas on acute and chronic models of liver injury[J]. Int J Biol Macromol, 2015, 78: 142-148.
侯丽,汪秋宽,何云海,等. 牡蛎多糖提取及其对小鼠急性酒精肝损伤的保护作用[J]. 食品工业科技,2014, 35(22): 356-358,370.
MURATA Y, TOUHATA K, MIWA R. Correlation of extractive components and body index with taste in oyster Crassostrea gigas brands[J]. Fisheries Sci, 2020, 86(3): 561-572.
谭乐义,章超桦,薛长湖,等. 牛磺酸的生物活性及其在海洋生物中的分布[J]. 湛江海洋大学学报,2000, 20(3): 75.
TANAKA K, NISHIZONO S, KUGINO K, et al. Effects of dietary oyster extract on lipid metabolism, blood pressure, and blood glucose in SD rats, hypertensive rats, and diabetic rats[J]. Biosci Biotechnol Biochem, 2006, 70(2): 462-470.
TRAN N K, KWON J E, KANG S C, et al. Crassaostrea gigas oyster shell extract inhibits lipogenesis via suppression of serine palmitoyltransferase[J]. Nat Prod Commun, 2015, 10(2): 349-352.
YAO Z, LIANG G, LV Z L, et al. Taurine reduces liver damage in non-alcoholic fatty liver disease model in rats by down-regulating IL-9 and tumor growth factor TGF-β[J]. Bull Exp Biol Med, 2021,171(5): 638-643.
TANG R, YANG Q, LIN S, et al. Preventive or curative administration of taurine regulates lipid metabolism in the liver of rats with alcoholic liver disease[J]. Adv Exp Med Biol, 2019, 1155: 119-131.
姜画画,王宁丽,裴栋,等. 牡蛎肉营养成分分析及安全性评价[J]. 食品工业,2018, 39(11): 298-299.
DE CASTRO R J S, SATO H H. Biologically active peptides: processes for their generation, purification and identification and applications as natural additives in the food and pharmaceutical industries[J]. Food Res Int, 2015, 74: 185-198.
WANG X, YU H, XING R, et al. Hepatoprotective effect of oyster peptide on alcohol-induced liver disease in mice[J]. Int J Mol Sci, 2022, 23(15): 8081.
邓凯翔,黄津. 牡蛎肽对CCl4诱导肝纤维化大鼠核因子-κB、诱导型一氧化氮合成酶的影响[J]. 中国现代医药杂志,2021, 23(11): 1-4.
SUMAILY K M. The roles and pathogenesis mechanisms of a number of micronutrients in the prevention and/or treatment of chronic hepatitis, COVID-19 and Type-2 diabetes mellitus[J]. Nutrients, 2022, 14(13): 2632.
秦华伟,陈爱华,刘慧慧,等. 乳山海域养殖太平洋牡蛎中营养成分及重金属含量分析及评价[J]. 中国渔业质量与标准,2015, 5(6): 64-70.
0
浏览量
0
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构